QTORIN rapamycin NDA rolling review, 2H26 filing, 1H27 FDA approval outlook, cash burn & launch plans—read now.
Palvella Therapeutics (NASDAQ:PVLA) said it remains on track to complete its new drug application submission for QTORIN ...
MarketBeat on MSN
Martin Marietta Materials Q2 earnings call highlights
3 Stocks Helping Build Tomorrow's Data Centers Martin Marietta Materials (NYSE:MLM) reported record second-quarter revenue ...
In the past quarter, Martin Marietta Materials reported second-quarter 2026 sales of US$1,947 million, up from US$1,609 ...
Laredo Morning Times on MSN
Ask us 2026: Dean Senator Zaffirini backs ambulance billing limits and EMS funding in South Texas
Dean Sen. Judith Zaffirini backed ambulance billing limits and $10 million for EMS whole blood programs to improve emergency care in Texas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results